Brief Telehealth Cognitive Rehabilitation Following Mild TBI
On-TRACC
1 other identifier
interventional
28
1 country
1
Brief Summary
In the United States, more than a million people sustain a mild traumatic brain injury (mTBI) every year. Although many recover fully, emerging literature suggests a high number of individuals report chronic, and functionally disabling, cognitive difficulties. Among Veterans, a nationwide survey found that more than 75% of 55,000 Veterans with a history of mTBI reported persistent moderate to severe levels of forgetfulness and poor concentration. Reduced cognitive functioning following mTBI contributes to significant functional impairment, including underemployment, relationship difficulties, and reduced community integration for years post injury. Despite the significant individual and societal impact, evidence to guide interventions and treatment for this population remains limited. Even more limited are validated telehealth options for these symptoms, a critical means by which access to care can be improved, especially during the COVID-19 pandemic. The proposed pilot study will address this gap by evaluating the feasibility, acceptability, and preliminary effectiveness of a brief (5-session) cognitive rehabilitation intervention that was developed for individuals with mTBI and that will be administered over video-based telehealth technology. The development of this intervention was supported by a grant from the Department of Defense, with critical elements identified through surveys completed by clinicians and veterans with a history of mTBI, and also the clinical expertise of the team.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 13, 2021
CompletedStudy Start
First participant enrolled
December 13, 2021
CompletedFirst Posted
Study publicly available on registry
April 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 10, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 13, 2022
CompletedMarch 24, 2023
March 1, 2023
10 months
December 13, 2021
March 22, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Feasibility of administering the On-TRACC intervention to individuals with mTBI
Feasibility measures will include rate of enrollment of eligible individuals as well as dropout rate for enrolled participants. We will also evaluate participant adherence, including proportion of treatment sessions attended and number of days that homework was completed.
At the completion of 5 week intervention
Secondary Outcomes (4)
Participant satisfaction with On-TRACC intervention
End of each treatment session and at treatment completion, 5 weeks total.
Preliminary effectiveness of On-TRACC intervention in decreasing post-concussive symptoms
Baseline (pre-treatment) and at the end of the 5-week On-TRACC intervention, 5 week time-frame on average
Preliminary effectiveness of On-TRACC intervention at decreasing self-reported cognitive difficulties
Baseline (pre-treatment) and at the end of the 5-week On-TRACC intervention, 5 week time-frame on average
Preliminary effectiveness of On-TRACC intervention at improving self-efficacy
Baseline (pre-treatment) and at the end of the 5-week On-TRACC intervention, 5 week time-frame on average
Study Arms (1)
Brief Cognitive Rehabilitation
EXPERIMENTAL5-session Cognitive Rehabilitation intervention administered over telehealth
Interventions
5-session Cognitive Rehabilitation intervention that can be administered over telehealth.
Eligibility Criteria
You may qualify if:
- Age 18+;
- Read, speak, understand English;
- History of at least one mTBI;
- Endorses moderate to severe cognitive difficulties in one or more of Neurobehavioral Symptom Inventory items M-P;
- Ability and willingness to participate in audio recorded sessions over video telehealth platform in a private setting, including equipment and internet access;
- Lives within 2 hours of VA Puget Sound or affiliated clinics/University of Washington;
- Will be in Washington State when engaging in treatment sessions
You may not qualify if:
- Significant cognitive impairment that would limit ability to engage on treatment;
- Neurologic injury or illness that affects cognitive functioning, including history of moderate or severe TBI;
- History of TBI in the past 3 months, from the date of screening;
- History of serious mental illness involving psychotic symptoms;
- Current psychotic or manic symptoms;
- Current or active flag, or documentation in medical record, for behavior or suicide risk;
- Current (within the past 3 months) Substance Use Disorder (not including caffeine or nicotine disorder)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Washingtonlead
- VA Puget Sound Health Care Systemcollaborator
Study Sites (1)
VA Puget Sound Health Care System
Seattle, Washington, 98108, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kathleen Pagulayan, PhD
VA Puget Sound Health Care System/University of Washington
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, School of Medicine: Psychiatry
Study Record Dates
First Submitted
December 13, 2021
First Posted
April 7, 2022
Study Start
December 13, 2021
Primary Completion
October 10, 2022
Study Completion
October 13, 2022
Last Updated
March 24, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share